MARRONE BIO INNOVATIONS INC's ticker is MBII and the CUSIP is 57165B106. A total of 45 filers reported holding MARRONE BIO INNOVATIONS INC in Q3 2018. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $7,000 | -63.2% | 6,221 | -75.5% | 0.00% | – |
| Q4 2021 | $19,000 | +58.3% | 25,347 | +101.8% | 0.00% | – |
| Q3 2021 | $12,000 | +9.1% | 12,562 | +83.1% | 0.00% | – |
| Q2 2021 | $11,000 | -8.3% | 6,861 | +15.3% | 0.00% | – |
| Q1 2021 | $12,000 | +100.0% | 5,948 | +28.0% | 0.00% | – |
| Q4 2020 | $6,000 | – | 4,648 | +5936.4% | 0.00% | – |
| Q3 2020 | $0 | – | 77 | -82.5% | 0.00% | – |
| Q2 2020 | $0 | -100.0% | 441 | -87.4% | 0.00% | – |
| Q1 2020 | $3,000 | 0.0% | 3,506 | +102.1% | 0.00% | – |
| Q3 2018 | $3,000 | – | 1,735 | +2698.4% | 0.00% | – |
| Q2 2018 | $0 | – | 62 | +342.9% | 0.00% | – |
| Q4 2017 | $0 | – | 14 | 0.0% | 0.00% | – |
| Q3 2017 | $0 | -100.0% | 14 | -95.1% | 0.00% | – |
| Q3 2015 | $1,000 | 0.0% | 287 | 0.0% | 0.00% | – |
| Q2 2015 | $1,000 | – | 287 | +341.5% | 0.00% | – |
| Q1 2015 | $0 | -100.0% | 65 | -67.5% | 0.00% | – |
| Q3 2013 | $3,000 | – | 200 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ARDSLEY ADVISORY PARTNERS LP | 14,303,099 | $15,635,000 | 3.02% |
| ICM ASSET MANAGEMENT INC/WA | 21,500 | $26,000 | 0.14% |
| Fairpointe Capital LLC | 613,900 | $749,000 | 0.12% |
| WADDELL & REED FINANCIAL INC | 25,095,634 | $30,617,000 | 0.07% |
| WEDBUSH SECURITIES INC | 37,129 | $45,000 | 0.00% |
| Financial Advocates Investment Management | 30,925 | $38,000 | 0.00% |
| PRIMECAP MANAGEMENT CO/CA/ | 2,035,300 | $2,483,000 | 0.00% |
| Avior Wealth Management, LLC | 10,000 | $12,000 | 0.00% |
| AMALGAMATED BANK | 10,217 | $12,000 | 0.00% |
| Tower Research Capital LLC (TRC) | 73,897 | $90,000 | 0.00% |